Finanzwire Finanzwire
Basculer en Français
10846 Companies
235522 Keywords
164453 Articles
126200 Press releases
Headlines Articles Press releases Secarna Pharmaceuticals GmbH & Co. KG Remove
  1. Home
  2. Companies
  3. Secarna Pharmaceuticals GmbH & Co. KG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 11/03/2023 at 18:05, 2 years 9 months ago

    Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/25/2023 at 15:00, 2 years 9 months ago

    Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/17/2023 at 14:00, 2 years 10 months ago

    Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 07/06/2023 at 14:00, 3 years 1 month ago

    Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 06/05/2023 at 14:00, 3 years 2 months ago

    Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 03/27/2023 at 16:04, 3 years 4 months ago

    Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
Previous page
1 ... 3 4
Accesswire
  • Published on 08/18/2026 at 02:20, 7 hours 44 minutes ago

    Numerous High-Grade Assays Extend Tolmer Silver Discovery

  • Published on 08/18/2026 at 00:30, 9 hours 34 minutes ago

    NV Gold Announces Grant of Stock Options

  • Published on 08/17/2026 at 22:30, 11 hours 34 minutes ago

    Matador Technologies Amends Convertible Note Facility to Expand At the Market Capacity and Commit a Fixed Share of Proceeds to Bitcoin

  • Published on 08/17/2026 at 21:00, 13 hours 4 minutes ago

    Taranis Announces New Critical Minerals By-Product Findings at the Thor and Ajax Mines

  • Published on 08/17/2026 at 15:00, 19 hours 4 minutes ago

    Norsemont Appoints Ariel Tepperman to Its Board

View all ACCESSWIRE
EQS Group
  • Published on 08/18/2026 at 09:44, 20 minutes ago

    Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

  • Published on 08/18/2026 at 09:35, 29 minutes ago

    Cost-of-living crisis fuels expat fever as nearly half of Europeans expect to live abroad

  • Published on 08/18/2026 at 09:27, 37 minutes ago

    FamiCord AG to transfer to the Scale segment effective 19 August 2026

  • Published on 08/18/2026 at 09:23, 41 minutes ago

    Original-Research: Energiekontor AG (von First Berlin Equity Research GmbH): Buy

  • Published on 08/18/2026 at 09:05, 59 minutes ago

    How to Reduce Household Electricity Bills in Daily Life -- Sunshare Offers a New Solution

View all EQS
Les Echos
  • Published on 08/17/2026 at 19:45, 14 hours 19 minutes ago

    Aéroports de Paris S.A - July 2026 traffic figures

  • Published on 08/17/2026 at 17:45, 16 hours 19 minutes ago

    Weekly share buyback

  • Published on 08/17/2026 at 08:33, 1 day 1 hour ago

    Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026

  • Published on 08/17/2026 at 07:30, 1 day 2 hours ago

    Disclosure of transactions in own shares from August 10 to August 14, 2026

  • Published on 08/10/2026 at 18:00, 7 days 16 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy